HopeStage
Back to all studies
TerminatedISRCTN42386710

A double blind placebo controlled discontinuation of citalopram in adolescents with major depression

Research studyAges 13–18Canada
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.

Listed locations
Canada

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Terminated
Enrollment listed in the registry
Not clearly listed
Sponsor
Sunnybrook and Women's College Health Sciences Centre (Canada)
Sponsor type
University
Study type
Other
Intervention type
Other / unclear
Locations
Canada
Age range
From 13 Years to 18 Years
Official registry ID
ISRCTN42386710
Official title
Show the full official title

A double blind placebo controlled discontinuation of citalopram in adolescents with major depression

Recruitment & locations

Terminated

Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook and Women's College Health Sciences Centre (Canada), a university.

Who can participate?

This study is for people with depression. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies